Updated:
GlycoNet
GlycoNet is a pan-Canadian research network funded by the Networks of Centres of Excellence. It focuses on glycomics to address health issues and improve...
GlycoNet
GlycoNet is a pan-Canadian research network funded by the Networks of Centres of Excellence. It focuses on glycomics to address health issues and improve Canadians' quality of life. GlycoNet has made 5 investments, including a 2022 investment in Zucara, and has 1 portfolio exit, PanTHERA CryoSolutions, in 2025.
General information
Firm type
Other
Location
Region
North America
Country
Canada
City
Edmonton
Corporate office
Edmonton, Alberta, Canada
Sector focus
Frequently asked questions
Where is GlycoNet based?
GlycoNet is headquartered in Edmonton, Alberta, Canada. No additional office locations have been disclosed.
Does GlycoNet publicly disclose its assets under management?
GlycoNet has not publicly disclosed its AUM or deployment figures. Industry estimates are not available.
Who controls investment decisions at GlycoNet?
GlycoNet has not publicly named its principals, leadership, or investment committee members. The firm's governance structure is not documented in public sources.
What is the wealth origin behind GlycoNet?
The wealth origin of GlycoNet is not publicly disclosed. No family or individual has been associated with the entity in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: